Familial hyperlipidemia
MONDO:0001336An instance of hyperlipidemia (disease) that is caused by an inherited modification of the individual's genome.
Also known as: hyperlipemia, hyperlipidaemia, hereditary hyperlipidemia (disease), familial hyperlipemia, familial hyperlipoproteinemia
131 clinical trials for this condition and its sub-types, 8 tagged with Familial hyperlipidemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Familial hyperlipidemia
-
Familial hypercholesterolemia 58 trials · 94 incl. sub-types
5 sub-types
-
Hyperlipoproteinemia type 3 4 trials
-
Hyperlipoproteinemia type V 2 trials
-
Hyperlipidemia, combined, 2 0 trials
-
Hyperlipoproteinemia, type 1D 0 trials
-
Could a purified fish oil calm the 'hot' plaques that trigger heart attacks?
Disease control Not yet recruitingThis trial tests whether icosapent ethyl, a purified form of fish oil, can stabilize high-risk coronary plaques in people with heart disease. Participants have plaques that narrow a major heart artery by 30–70% and show at least one high-risk feature on a CT scan. Half will take …
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New team approach aims to simplify care for heart and kidney health
Disease control Not yet recruitingThis study tests a 6-month program where patients work with a pharmacist and their primary care doctor to make shared decisions about medications and lifestyle. The goal is to see if this team-based approach improves heart and kidney health scores and medication adherence. The st…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC